4th TRP Supply Chain & Manufacturing Summit (September 15–17, 2026 | Boston, MA)

Radiopharmaceuticals are entering a defining stage of development. As clinical programs advance into Phase II, Phase III, and commercial readiness, the ability to manufacture and deliver therapies reliably has become one of the industry’s greatest challenges. Rising demand for isotopes, infrastructure constraints, workforce shortages, evolving regulatory expectations, and the unique realities of short half-life materials are placing unprecedented pressure on supply chain and manufacturing teams.

The 4th TRP Supply Chain & Manufacturing Summit is the only industry-focused forum dedicated exclusively to the supply chain, manufacturing, CMC, quality, and logistics challenges impacting radiopharmaceutical development. Bringing together 60+ senior leaders from pharma, biotech, CDMOs, isotope providers, and logistics organizations, the meeting is designed to help attendees overcome the operational bottlenecks that stand between scientific breakthroughs and patient delivery.

Across two conference days and interactive workshops, attendees will gain practical insights to:

• Strengthen isotope supply resilience across established and emerging alpha and beta emitters
• Scale manufacturing operations to support late-stage clinical trials and commercialization
• Evaluate build vs. buy manufacturing strategies and optimize CDMO partnerships
• Implement automation and digital solutions to improve consistency, throughput, and compliance
• Optimize logistics and distribution networks for time-sensitive radiopharmaceutical therapies
• Navigate evolving regulatory expectations with greater confidence and preparedness

Featuring experts from AstraZeneca, Bayer, Telix Pharmaceuticals, Cellectar Biosciences, Ratio Therapeutics, Convergent Therapeutics, Molecular Partners AG, Purdue University, and the University of Alabama at Birmingham, the summit delivers real-world case studies and practical strategies from organizations actively addressing today’s most pressing supply chain and manufacturing challenges.

With 10+ hours of dedicated networking, attendees can benchmark approaches, exchange lessons learned, and build the partnerships needed to move radiopharmaceutical therapies from bench to patient reliably and at scale.